I noticed in the recent Beacon Securities coverage of Resverlogix by analyst David M. Kideckel that Bioasis made it onto Beacon Securities Biotech/Healthcare Initial "Watch List". Also interesting that David M. Kideckel and Mark Day both spent time at Alexion, though I'm not sure if they overlapped. I think the link below will open up the Resverlogix report and the watch list is on page 6.
CLICK HERE TO VIEW FULL REPORT